- Report
- July 2023
- 132 Pages
Global
From €903EUR$950USD£776GBP
- Report
- April 2020
- 240 Pages
Global
€5400EUR$6,089USD£4,808GBP
- Report
- October 2022
- 309 Pages
Global
From €3648EUR$3,840USD£3,138GBP
- Report
- May 2023
- 147 Pages
Global
From €5699EUR$5,999USD£4,903GBP
- Report
- December 2023
- 108 Pages
Global
From €4038EUR$4,250USD£3,473GBP
- Book
- September 2023
- 384 Pages
- Book
- October 2020
- 384 Pages
- Book
- October 2020
- 432 Pages
- Book
- June 2019
- 304 Pages
- Book
- January 2016
- 472 Pages
- Book
- November 2013
- 744 Pages
- Book
- September 2010
- 984 Pages
- Book
- September 2009
- 306 Pages
The Peptide market is a subset of the biopharmaceutical industry, which focuses on the development and production of therapeutic proteins and peptides. Peptides are short chains of amino acids that are used to treat a variety of diseases, including cancer, diabetes, and autoimmune disorders. Peptides are typically produced through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Peptide market is highly competitive, with a number of companies offering a variety of products. Companies in the market are focused on developing and manufacturing peptides for therapeutic use, as well as providing services such as peptide synthesis and purification. Additionally, some companies are involved in the development of peptide-based drug delivery systems.
Notable companies in the Peptide market include Novo Nordisk, Merck, Sanofi, and Pfizer. Other companies include AbbVie, Amgen, and Genentech. Show Less Read more